|
Lynwood pregunto:
What sort of music do you listen to? <a href=" https://www.prolateral.com/what-if-the-pharmacy-gives-you-the-wrong-prescription.pdf#travels ">best drugstore primer for redness</a> Shareholder activism on the part of hedge funds has, over the past decade, played an increasingly important, and high-profile, role in the market, with money managers like Ackman, Daniel Loeb, of Third Point, and Carl Icahn taking sizeable (though usually minority) stakes in undervalued or struggling companies and then agitating for change. That change-seeking has typically focussed on management—replacing C.E.O.s or board members—or on what’s usually called “financial engineering”: pushing companies to buy back shares, raise dividends, sell off underperforming divisions, and so on. And this approach seems to have been, on the whole, pretty successful: one comprehensive 2008 study of hundreds of activist campaigns between 2001 and 2006, for instance, found that companies targeted by activists didn’t just see their stock prices outperform forecasts but also saw their profitability and operating performance improve. |
|
|
|
